Cancer Pain
📧 Sign up to get email alerts when something new happens for Cancer Pain.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-08-31Clinical Trial Update: Opioid Titration With 12.5 ug/h Fentanyl Transdermal Patch vs Orally Morphine for Opioid-naïve Patients With Moderate Cancer Pain [Phase 3]
Phase 3 trial comparing 12.5 mcg/h fentanyl transdermal patch titration with oral morphine for opioid-naïve patients experiencing moderate c…
-
CLINICAL_TRIALS trial_result · 2019-06-11Clinical Trial Update: A Study to Evaluate Buprenorphine Transdermal Patch in Chinese Subjects With Moderate to Severe Chronic Cancer Pain [Phase 3]
A Phase 3 clinical trial evaluating a buprenorphine transdermal patch for moderate to severe cancer pain in Chinese subjects.
-
CLINICAL_TRIALS trial_result · 2018-11-19Clinical Trial Update: An Interventional Study for Patient With Cancer Pain to Evaluate the Efficacy and Safety of OxyNorm® Compared to Morphine Sulfate Through the IV Continuous Infusion. [Phase 4]
A Phase 4 interventional trial comparing OxyNorm to morphine sulfate via IV infusion in cancer pain patients has completed with results post…
-
CLINICAL_TRIALS trial_result · 2018-10-24Clinical Trial Update: A Study to Assess the Safety and Tolerability of Oxycodone Hydrochloride 50mg/mL Administered as an Infusion [Phase 3]
Phase 3 trial investigating safety and tolerability of high-dose oxycodone hydrochloride infusion; study terminated.
-
CLINICAL_TRIALS trial_result · 2018-04-23Clinical Trial Update: Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer [Phase 3]
Phase 3 trial results for Sativex (nabiximols) assessing relief of persistent pain in participants with advanced cancer, with results posted…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-06-09Clinical Trial Update: Coaching to Improve Care of Cancer Pain [NA]
Clinical trial update indicating completion of a study evaluating coaching to improve care of cancer-related pain.
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Validation and Assessment of Patient Adherence to Opioids for Cancer Pain Using MMAS 8 Pain Clinic
Completed clinical trial from Tata Memorial Centre evaluating validation and patient adherence to opioid therapy for chronic cancer pain usi…
-
CLINICAL_TRIALS trial_result · 2016-11-04Clinical Trial Update: To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain [Phase 2, Phase 3]
Phase 2/3 study evaluating whether higher-dose OXN PR is equivalent to lower-dose OXN PR in pain relief and bowel function in patients with …
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Analgesic Treatment for Cancer Pain in South East Asia
This document reports the completion of a clinical trial evaluating an analgesic treatment for cancer-related pain in Southeast Asia. The re…
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Acetaminophen for Cancer Pain [Phase 3]
A Phase 3 trial evaluating acetaminophen for cancer-related pain has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-31Clinical Trial Update: IncobotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation [Phase 2]
Phase 2 trial of incobotulinumtoxinA for focal cancer pain after surgery and/or radiation. The study was terminated and results were posted …
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: RCT Comparing the Analgesic Efficacy of 4 Therapeutic Strategies Based on 4 Different Major Opioids (Fentanyl, Oxycodone, Buprenorphine vs Morphine) in Cancer Patients With Moderate/Severe Pain, at the Moment of Starting 3rd Step of WHO Analgesic Ladder. [Phase 4]
Phase 4 randomized trial compares analgesic efficacy of four opioid strategies (fentanyl, oxycodone, buprenorphine, morphine) for moderate-t…
-
CLINICAL_TRIALS trial_result · 2015-07-28Clinical Trial Update: Magnesium Associated With Morphine for Cancer Pain Relief [NA]
A completed clinical trial from the Federal University of São Paulo evaluated magnesium in combination with morphine for cancer-related pain…
-
CLINICAL_TRIALS trial_result · 2015-06-01Clinical Trial Update: Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related Pain [Phase 3]
A Phase 3 trial evaluated efficacy and safety of a treatment for opioid-induced constipation in patients with cancer-related pain. The study…
-
CLINICAL_TRIALS trial_result · 2015-01-01Clinical Trial Update: A Study for the Evaluation of the Safety, Tolerability, and Efficacy of ARX-F02 (Sufentanil NanoTab) Compared to Placebo in the Treatment of Cancer Breakthrough Pain [Phase 2]
Phase 2 study evaluating the safety, tolerability, and efficacy of ARX-F02 (Sufentanil NanoTab) versus placebo for cancer breakthrough pain;…
-
CLINICAL_TRIALS trial_result · 2014-01-15Clinical Trial Update: A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain [Phase 3]
Phase 3 trial updates on safety and efficacy of JNS024 ER for chronic malignant tumor-related cancer pain in Japanese and Korean patients, w…
-
CLINICAL_TRIALS trial_result · 2013-10-11Clinical Trial Update: Safety and Efficacy Study of Osmotic Release Oral System (OROS) Hydromorphone in Participants With Cancer Pain [Phase 4]
A Phase 4 safety and efficacy study of OROS hydromorphone for cancer-related pain was terminated, with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-08-26Clinical Trial Update: An Efficacy and Safety Study of Hydromorphone Oral Osmotic System (OROS) in Korean Participants With Cancer Pain [Phase 4]
A Phase 4 clinical trial evaluating the efficacy and safety of the hydromorphone oral osmotic system (OROS) for cancer pain in Korean partic…
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: A Study to Compare Safety and Efficacy of Osmotic Release Oral Syytem (OROS) Hydromorphone Hydrochloride (HCl) With Morphine Sustain Release (SR) in Participants With Cancer Pain [Phase 3]
A Phase 3 trial comparing Osmotic Release Oral System hydromorphone hydrochloride with sustained-release morphine for cancer pain was termin…
-
CLINICAL_TRIALS trial_result · 2013-08-07Clinical Trial Update: Efficacy of Low Analgesic Doses of Ketamine Associated With Opioids in Refractory Cancer Pain Treatment [Phase 3]
A Phase 3 trial evaluating low-dose ketamine in combination with opioids for refractory cancer pain has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-21Clinical Trial Update: A Dose-Finding Study of Fentanyl (JNS020 QD) 1-Day Transdermal Patch in Participants With Cancer Pain [Phase 2, Phase 3]
This update reports the results of a Phase 2/3 dose-finding study of the fentanyl JNS020 QD 1-day transdermal patch in cancer-related pain, …
-
CLINICAL_TRIALS trial_result · 2013-03-21Clinical Trial Update: A Clinical Trial to Assess the Clinical Benefit of SSR411298 as Adjunctive Treatment for Persistent Cancer Pain [Phase 2]
A Phase 2 clinical trial evaluating SSR411298 as an adjunctive treatment for persistent cancer pain has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Case-control Study- Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients (Fentanyl)
A completed case-control study investigated whether uncontrolled cancer pain predicts the development of depression in oncologic patients, w…
-
CLINICAL_TRIALS trial_result · 2012-09-10Clinical Trial Update: Opioid Titration in the Hospice Setting: Barriers Assessment and Modification of the Model Order Sheet and Protocol
Completed clinical trial from Vanderbilt-Ingram Cancer Center evaluating opioid titration in hospice cancer pain to identify barriers and to…
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Efficacy and Safety of FITpatch Compared to Standard Opioid Treatment in Cancer Pain (FT-015-IN) [Phase 3]
Phase 3 trial comparing FITpatch with standard opioid therapy for cancer-related chronic pain has completed, evaluating efficacy and safety.